(ATE) Alten - Overview
Stock: Consulting, Engineering, Technology
Dividends
| Dividend Yield | 2.08% |
| Yield on Cost 5y | 1.75% |
| Yield CAGR 5y | 10.67% |
| Payout Consistency | 85.1% |
| Payout Ratio | 35.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 49.6% |
| Relative Tail Risk | -6.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.30 |
| Alpha | -24.30 |
| Character TTM | |
|---|---|
| Beta | 0.269 |
| Beta Downside | 0.699 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.10% |
| CAGR/Max DD | -0.35 |
Description: ATE Alten January 12, 2026
Alten S.A. (ticker ATE) is a French-headquartered engineering and technology consultancy that delivers a broad portfolio of services across Europe, North America and the Asia-Pacific. Its footprint spans France, Germany, Scandinavia, Benelux, Iberia, Italy, the United Kingdom, Switzerland, Eastern Europe and international markets.
The firm supports corporate, telecom and service clients in R&D, information systems and technical divisions, offering engineering expertise (mechanics, materials, systems engineering, PDM, quality assurance, manufacturing, HSE, electronics, and infrastructure) as well as IT capabilities (business analysis, cybersecurity, AI, application development, data management, green IT, embedded software, testing, cloud and infrastructure).
Alten serves a diversified set of end-markets-including aeronautics, space, defense, automotive, rail, energy, life sciences, finance, telecoms, retail, media and public-sector entities. In FY 2023 the company reported revenue of roughly €3.5 billion with an EBITDA margin near 6%, reflecting steady demand for digital-transformation projects. The global IT-consulting market is projected to grow at a 5 % CAGR through 2028, while rising defense budgets in Europe and accelerated adoption of AI and cybersecurity services are key tailwinds for Alten’s core segments.
For a deeper dive into Alten’s valuation metrics and scenario analysis, check out the detailed research page on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 391.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA 15.01 > 1.0 |
| NWC/Revenue: 7.62% < 20% (prev 18.54%; Δ -10.92% < -1%) |
| CFO/TA 0.21 > 3% & CFO 775.9m > Net Income 391.1m |
| Net Debt (35.8m) to EBITDA (849.3m): 0.04 < 3 |
| Current Ratio: 1.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (35.1m) vs 12m ago 0.85% < -2% |
| Gross Margin: 16.01% > 18% (prev 0.10%; Δ 1591 % > 0.5%) |
| Asset Turnover: 234.2% > 50% (prev 116.7%; Δ 117.5% > 0%) |
| Interest Coverage Ratio: 25.27 > 6 (EBITDA TTM 849.3m / Interest Expense TTM 25.9m) |
Altman Z'' 4.12
| A: 0.17 (Total Current Assets 1.78b - Total Current Liabilities 1.15b) / Total Assets 3.61b |
| B: 0.02 (Retained Earnings 82.6m / Total Assets 3.61b) |
| C: 0.19 (EBIT TTM 655.1m / Avg Total Assets 3.52b) |
| D: 1.57 (Book Value of Equity 2.23b / Total Liabilities 1.42b) |
| Altman-Z'' Score: 4.12 = AA |
Beneish M -3.00
| DSRI: 0.48 (Receivables 1.43b/1.45b, Revenue 8.25b/4.01b) |
| GMI: 0.60 (GM 16.01% / 9.64%) |
| AQI: 1.27 (AQ_t 0.43 / AQ_t-1 0.34) |
| SGI: 2.06 (Revenue 8.25b / 4.01b) |
| TATA: -0.11 (NI 391.1m - CFO 775.9m) / TA 3.61b) |
| Beneish M-Score: -3.00 (Cap -4..+1) = AA |
What is the price of ATE shares?
Over the past week, the price has changed by -14.41%, over one month by -1.67%, over three months by +5.52% and over the past year by -17.75%.
Is ATE a buy, sell or hold?
What are the forecasts/targets for the ATE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 101.2 | 43.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 67.9 | -4% |
ATE Fundamental Data Overview February 03, 2026
P/E Trailing = 19.2541
P/E Forward = 9.7847
P/S = 0.6992
P/B = 1.1241
Revenue TTM = 8.25b EUR
EBIT TTM = 655.1m EUR
EBITDA TTM = 849.3m EUR
Long Term Debt = 6.99m EUR (from longTermDebt, last quarter)
Short Term Debt = 134.9m EUR (from shortTermDebt, last quarter)
Debt = 312.7m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 35.8m EUR (from netDebt column, last quarter)
Enterprise Value = 2.92b EUR (2.88b + Debt 312.7m - CCE 276.9m)
Interest Coverage Ratio = 25.27 (Ebit TTM 655.1m / Interest Expense TTM 25.9m)
EV/FCF = 3.92x (Enterprise Value 2.92b / FCF TTM 743.6m)
FCF Yield = 25.50% (FCF TTM 743.6m / Enterprise Value 2.92b)
FCF Margin = 9.01% (FCF TTM 743.6m / Revenue TTM 8.25b)
Net Margin = 4.74% (Net Income TTM 391.1m / Revenue TTM 8.25b)
Gross Margin = 16.01% ((Revenue TTM 8.25b - Cost of Revenue TTM 6.93b) / Revenue TTM)
Gross Margin QoQ = 7.02% (prev 18.67%)
Tobins Q-Ratio = 0.81 (Enterprise Value 2.92b / Total Assets 3.61b)
Interest Expense / Debt = 1.49% (Interest Expense 4.67m / Debt 312.7m)
Taxrate = 31.01% (37.1m / 119.7m)
NOPAT = 451.9m (EBIT 655.1m * (1 - 31.01%))
Current Ratio = 1.54 (Total Current Assets 1.78b / Total Current Liabilities 1.15b)
Debt / Equity = 0.14 (Debt 312.7m / totalStockholderEquity, last quarter 2.19b)
Debt / EBITDA = 0.04 (Net Debt 35.8m / EBITDA 849.3m)
Debt / FCF = 0.05 (Net Debt 35.8m / FCF TTM 743.6m)
Total Stockholder Equity = 2.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.10% (Net Income 391.1m / Total Assets 3.61b)
RoE = 18.26% (Net Income TTM 391.1m / Total Stockholder Equity 2.14b)
RoCE = 30.49% (EBIT 655.1m / Capital Employed (Equity 2.14b + L.T.Debt 6.99m))
RoIC = 20.14% (NOPAT 451.9m / Invested Capital 2.24b)
WACC = 6.33% (E(2.88b)/V(3.19b) * Re(6.91%) + D(312.7m)/V(3.19b) * Rd(1.49%) * (1-Tc(0.31)))
Discount Rate = 6.91% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.05%
[DCF Debug] Terminal Value 85.00% ; FCFF base≈522.8m ; Y1≈545.2m ; Y5≈627.6m
Fair Price DCF = 465.7 (EV 16.27b - Net Debt 35.8m = Equity 16.24b / Shares 34.9m; r=6.33% [WACC]; 5y FCF grow 4.55% → 2.90% )
EPS Correlation: -25.53 | EPS CAGR: -34.00% | SUE: 0.0 | # QB: 0
Revenue Correlation: 92.31 | Revenue CAGR: 33.30% | SUE: 0.73 | # QB: 0
EPS next Year (2026-12-31): EPS=7.45 | Chg30d=+0.273 | Revisions Net=+2 | Growth EPS=+11.7% | Growth Revenue=+2.4%